Suppr超能文献

下丘脑错构瘤的手术入路。

Surgical approaches to hypothalamic hamartomas.

机构信息

Division of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA.

出版信息

Neurosurg Focus. 2011 Feb;30(2):E2. doi: 10.3171/2010.11.FOCUS10250.

Abstract

OBJECT

Hypothalamic hamartomas (HHs) are devastating lesions causing refractory epilepsy, rage attacks, social ineptitude, and precocious puberty. Microsurgical and/or endoscopic resection offers an excellent risk/benefit profile for cure or improvement of epilepsy.

METHODS

The authors reviewed a prospective database maintained during the first 7 years of the Barrow Hypothalamic Hamartoma program. They describe and illustrate their surgical methods, and they review data from several previous publications regarding surgical outcome.

RESULTS

To date, the authors have performed surgery in 165 patients for symptomatic HHs. Patients underwent an endoscopic, transcallosal, or skull base approach, or multiple approaches. Twenty-six patients (15.8%) required more than 1 treatment for their HH.

CONCLUSIONS

Microsurgical and endoscopic resection of symptomatic HHs are technically demanding but can be performed safely with excellent results and an acceptable risk profile. Meticulous attention to the subtleties of surgical management helps optimize outcomes.

摘要

目的

下丘脑错构瘤(HHs)是一种破坏性病变,可导致难治性癫痫、愤怒发作、社交无能和性早熟。显微外科和/或内镜切除为治愈或改善癫痫提供了极好的风险/获益比。

方法

作者回顾了巴罗下丘脑错构瘤项目前 7 年期间维持的前瞻性数据库。他们描述并说明了他们的手术方法,并回顾了之前关于手术结果的几个出版物的数据。

结果

迄今为止,作者已为 165 例有症状的 HHs 患者进行了手术。患者接受了内镜经胼胝体、颅底或多种方法的治疗。26 名患者(15.8%)需要对其 HH 进行 1 次以上的治疗。

结论

有症状的 HHs 的显微外科和内镜切除技术要求很高,但可以安全地进行,结果优异,风险状况可接受。对手术管理细节的细致关注有助于优化结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验